Krónikus gyulladásos demielinizációs polineuropátia (CIDP): vizsgálatok itt: Kína
13 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jiazhuang, Jinan, Nanchang, Shanghai, Wuhan, Xi'an
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Beijing, Fuzhou, Guangzhou, Guanzhou, Nanchang, Suzhou, Xi’an
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - 2/3. fázisFut, nem toborozEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chifeng, Fuzhou, Guangzhou, Jinan, Nanchang, Shanghai, Wuhan, Xi'an, Xi’an
- Életkor
- 18 év and over
- People
- 201 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05327114 · EU 2023-508425-28-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Beijing, Changsha, Chengdu, Chifeng, Fujian, Guangdong, Guangzhou, Hefei, Jilin City, Shanghai, Sichuan, Suzhou, Taiyuan, Wuhan
- Életkor
- 18 év to 75 év
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - 3. fázisCsak meghívásosLong-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan, Xi'an
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00 - 1/2. fázisTaking peopleSafety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év to 60 év
- People
- 27
- Run by
- Tianjin Medical University General Hospital
See details and how to joinNCT07022197 - No phaseTaking peopleBiomarkers in Autoimmune Disease of Nervous System
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 50 000
- Run by
- Tongji Hospital
See details and how to joinNCT06502015 - Korai 1. fázisTaking peopleCD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT07337785 - 1. fázisTaking peopleSafety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Tongji Hospital
See details and how to joinNCT07526493 - No phaseNot yet taking people in KínaTongji NADs Cohort
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 1550
- Run by
- Tongji Hospital
See details and how to joinNCT07333196 - Korai 1. fázisTaking peopleUniversal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 12
- Run by
- Tianjin Huanhu Hospital
See details and how to joinNCT06939166 - Korai 1. fázisNot yet taking people in KínaUniversal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06485232 - Korai 1. fázisTaking peopleSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT04561557